July 3, 2012 — Despite the rising incidence of peripheral arterial disease (PAD), there has been little data available on the prevalence and clinical correlates of sub-clinical atherosclerosis in the peripheral arteries in large population-based samples. Researchers at NewYork-Presbyterian/Weill Cornell Medical Center, led by primary investigator Dr. Ingrid Hriljac, have addressed this gap by performing ultrasound exams of the popliteal (behind the knee) and carotid arteries in the fifth examination of the Strong Heart Study (SHS), which included 3,240 members of 65 multi-generation families. The Strong Heart Study (SHS) is an epidemiologic survey of cardiovascular risk factors and disease in 13 native American tribes in three regions, with initial exam of 4,549 participants from 1989 to 1992.

A poster based on the study, which looked for the presence and degree of popliteal arterial plaque as a predictor of atherosclerosis throughout the arteries of the body. This poster will be presented on Sunday, July 1 from 9:30 a.m. to 4:30 p.m. in the exhibit and poster hall during the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions. Investigators will be available in the hall from 12:15 p.m. to 1:45 p.m. The ASE Scientific Sessions will be held from June 27 through July 3, 2012, at the Gaylord National in National Harbor, MD.

According to Dr. Hriljac, researchers found that in a young population (<40 years old) with high prevalence of obesity and diabetes, popliteal artery atherosclerosis is prevalent and independently associated with older age and greater leakage of albumin in the urine (known as albuminuria) — a known marker of end organ damage in diabetes. This study was able to provide a link between urinary albuminuria and severity of atherosclerotic plaque burden in the popliteal arteries. These findings also support albuminuria as a marker of disease of large lower extremity arteries as well as of small vessel disease in young individuals with type 2 diabetes.


Related Content

News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Breast Imaging

Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...

Time March 03, 2025
arrow
News | Focused Ultrasound Therapy

Jan. 8, 2025 - EDAP TMS SA, a supplier of robotic energy-based therapies, has announced that the first patient has been ...

Time January 08, 2025
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
Feature | Women's Health | By Jordan Bazinsky

Investing in women’s health should not merely be a metric on the equity dashboard — it should drive policy and tactical ...

Time July 08, 2024
arrow
Subscribe Now